Department of Human Genetics, Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research, Chennai, 600116, Tamil Nadu, India; Department of Biotechnology, Indian Institute of Technology, Madras, Chennai, 600036, Tamil Nadu, India.
Department of Biotechnology, Indian Institute of Technology, Madras, Chennai, 600036, Tamil Nadu, India.
Exp Cell Res. 2021 Jun 15;403(2):112613. doi: 10.1016/j.yexcr.2021.112613. Epub 2021 Apr 24.
The Hippo signaling pathway is a tumor suppressor pathway that plays an important role in tissue homeostasis and organ size control. KIBRA is one of the many upstream regulators of the Hippo pathway. It functions as a tumor suppressor by positively regulating the core Hippo kinase cascade. However, there are accumulating shreds of evidence showing that KIBRA has an oncogenic function, which we speculate may arise from its functions away from the Hippo pathway. In this review, we have attempted to provide an overview of the Hippo signaling with a special emphasis on evidence showing the paradoxical role of KIBRA in cancer.
Hippo 信号通路是一种肿瘤抑制通路,在组织稳态和器官大小控制中发挥重要作用。KIBRA 是 Hippo 通路的众多上游调节剂之一。它通过正向调节核心 Hippo 激酶级联反应发挥肿瘤抑制作用。然而,越来越多的证据表明 KIBRA 具有致癌功能,我们推测这可能源于其 Hippo 通路以外的功能。在这篇综述中,我们试图提供 Hippo 信号通路的概述,特别强调表明 KIBRA 在癌症中具有矛盾作用的证据。